CClinicalTrials.gg
CompletedNCT06217549Updated Jan 23, 2024

Effect of Ozone Therapy on Aerobic Exercise Performance

An interventional study of ozone therapy in Ozone Therapy and Exercise Performance, sponsored by Istanbul University. Completed at 1 site in Turkey. Open to male participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-23.

Sponsored by Istanbul University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 4 years 4 months after the study started (first participant enrolled Aug 2019, registered Jan 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Not applicable
Ages
18 Years to 35 Years
Sex
Male
01

Study summary

The goal of this clinical trial is to investigate the effect of the ozone therapy applied using the major autohemotherapy method on exercise performance in male healthy individuals.

The main question's aims to answer are:

  • Is ozone therapy applied with the major autohemotherapy method increase the performance?
  • Is ozone therapy applied with the major autohemotherapy method improve the recovery after exercise?
  • Participants are asked to continue the same exercise program throughout the study. They were given 10 sessions of ozone therapy over 6 weeks.

Researchers compared the before and after treatment performance and recovery data.

Read the detailed description

Medical ozone is a mixture of pure ozone gas (0.05-5%) and pure oxygen (99.95-95%). It is produced from pure medical oxygen by medical ozone generators. It is suggested that ozone therapy, which is used to treat a wide variety of diseases and is especially useful in the treatment of tissue ischemia and cardiovascular disorders, creates a mild, temporary and controlled oxidative stress and modulates the antioxidant system and immune system. It was reported that ozone exerted its effects by induction of reactive oxygen species and lipid oxygen products known as ozonides. The therapy modulates the immune system by balancing inflammatory and anti-inflammatory cytokines, increasing antioxidant enzymes and increasing glutathione production. In addition, it increases the production of 2,3-diphosphoglycerate (2,3-DPG) by causing an increase in the rate of red blood cell (RBC) glycolysis, improves red cell rheology, increases the oxidative carboxylation of pyruvate, and activates the hexose monophosphate pathway by stimulating adenosine triphosphate (ATP) production. With a decrease in potential of hydrogen (pH) and a slight increase in 2,3-DPG, the sigmoid curve of oxyhemoglobin shifts to the right due to the Bohr effect. The shift to the right reduces the chemical binding of oxygen to hemoglobin, facilitating oxygen delivery to ischemic tissues. Considering that the most important determinant of exercise performance is tissue oxygenation and that the antioxidant system has a positive effect on fatigue, these data lead to the idea that ozone can improve exercise performance.

There are a few studies in the literature investigating the effect of major ozone treatment on exercise performance. The arguments suggesting that major ozone therapy is effective in exercise performance are based on publications made outside of this subject, which include the mechanism of action of major ozone therapy.

Thus, it was aimed to evaluate the effects of the ozone therapy applied using the major autohemotherapy method on exercise performance with changes in fatigue, exercise duration, blood lactate changes level, anaerobic threshold, and maximal oxygen consumption (VO2max).

02

Conditions studied

  • Ozone Therapy
  • Exercise Performance
03

In context

Lead sponsor

Istanbul University is the lead sponsor of 496 studies on the registry; 79 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • male
  • healthy
  • aged between 18-35 years old

Exclusion criteria

Exclusion Criteria:

  • suffering from a low back or lower extremity injury or surgical operation in the last one year
  • having cardiovascular disease
  • having glucose 6 phosphate dehydrogenase enzyme deficiency
  • having chronic metabolic disease
  • having hyperthyroidism, mental and psychological problems.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
17 participants (actual)

Study arms

  • Experimental
    healthy participants

    healthy, physically active people will be included the study.

    Other: ozone therapy

Interventions

  • Otherozone therapy

    Medical ozone is a mixture of pure ozone gas (0.05-5%) and pure oxygen (99.95-95%). It is produced from pure medical oxygen by medical ozone generators. It is applied to the participants 10 sessions by the intravenous method.

06

What researchers measure

Primary outcomes

  1. VO2max

    maximum oxygen consumption, indicator of aerobic capacity, cardiopulmonary exercise tests performed twice for each participant

    Time frame: just before the first ozone therapy session and immediately after the last ozone therapy session

  2. exercise duration

    duration of cardiopulmonary exercise test

    Time frame: just before the first ozone therapy session and immediately after the last ozone therapy session

  3. Modified Borg Scale

    Modified Borg Scale is used to measure the perceived fatigue level. The participants were asked to rate their perceived fatigue on a scale of 1-10. It was expressed as 1 'no fatigue' and 10 'extreme fatigue (exhaustion).

    Time frame: just before the first ozone therapy session and immediately after the last ozone therapy session

  4. Lactate levels

    lactate levels at the end of the each 3-minute grades of each cardiopulmonary exercise tests

    Time frame: just before the first ozone therapy session and immediately after the last ozone therapy session

07

Study locations

1 site
  • Şensu Dinçer
    Istanbul, 34093, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06217549
Lead sponsor
Istanbul University
Responsible party
Şensu Dinçer (medical doctor, Istanbul University) — Principal investigator
First posted
Jan 22, 2024
Start date
Aug 12, 2019
Primary completion
Jan 31, 2020
Completion
Jan 31, 2020
Last update
Jan 23, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion